L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy

J Pharmacol Sci. 2022 Jan;148(1):31-40. doi: 10.1016/j.jphs.2021.09.006. Epub 2021 Sep 25.

Abstract

Ingestion of amino acids is fundamental for cellular activity. Amino acids are important components for protein synthesis but are also crucial for intracellular metabolic reactions and signal transduction. Following activation, immune cells induce metabolic reprogramming to generate adequate energy and constitutive substances. Hence, the delivery of amino acids by transporters is necessary for the progression of metabolic rewiring. In this review, we discuss how amino acids and their transporters regulate immune cell functions, with emphasis on LAT1, a transporter of large neutral amino acids. Furthermore, we explore the possibility of targeting amino acid transporters to improve immune disorders and cancer immune therapies.

Keywords: Amino acid transporter; Cancer immunotherapy; Inflammatory disease; LAT1; T cell.

Publication types

  • Review

MeSH terms

  • Gene Expression*
  • Humans
  • Immunotherapy / methods*
  • Inflammation / genetics*
  • Inflammation / immunology*
  • Inflammation / therapy
  • Large Neutral Amino Acid-Transporter 1 / genetics
  • Large Neutral Amino Acid-Transporter 1 / metabolism
  • Large Neutral Amino Acid-Transporter 1 / physiology*
  • Molecular Targeted Therapy
  • Neoplasms / genetics*
  • Neoplasms / immunology*
  • Neoplasms / therapy
  • T-Lymphocytes / immunology*

Substances

  • Large Neutral Amino Acid-Transporter 1
  • SLC7A5 protein, human